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DNA ploidy has been shown to be a predictive parameter for
prognosis in various solid tumours. The prognostic value of
DNA-ploidy in gastric cancers is still a matter of controversy.
A possible explanation for the discrepant results reported in
the literature could be sampling error in tumours with multi-
ple stemlines differing in DNA-ploidy.
In order to determine whether or not such heterogeneity
exists in early gastric carcinoma, we have performed DNA
cytophotometry on multiple samples of a group of 17 early
gastric carcinomas, of which 8 were pure intramucosal and 9
were infiltrating into the submucosa.
We found an aneuploid DNA-stemline in 8 (47%) early
gastric cancers, more often in tumours invading into the sub-
mucosa (5/9) than in purely mucosal tumours (3/8). Multiple
DNA-stemlines were found more frequently in submucosally
infiltrating tumours (4/5).
These results confirm the presence of DNA-aneuploid
early gastric carcinoma which are frequently heterogeneous
and suggest that heterogeneity occurs more frequently in tu-
mours invading the submucosa. This heterogeneity is best de-
tected by analysing multiple samples of tumours for DNA-
ploidy.
1. Introduction
Several studies have reported a correlation between
DNA-ploidy and prognosis in gastric carcinomas [1,7–
9,20,21,28]. Other studies have indicated that there is
no correlation between prognosis and DNA-ploidy [3].
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As explanation for this discrepancy several possibil-
ities come into consideration. These studies differ in
methodology (static vs. flow cytometry; tissue prepa-
ration), in their definition of DNA-aneuploidy, in the
number of patients studied. All these variables might
affect the final result.
Tumour heterogeneity, the presence within the same
tumour of multiple stemlines differing in DNA con-
tent, has been described in various tumours [10,14,16,
18,24,28]. The occurrence of such cellular heterogene-
ity in gastric carcinomas might yet be another explana-
tion of the divergent DNA-ploidy results in this type of
tumour.
In a previous study on DNA-ploidy in early gastric
carcinomas with focal advanced gastric carcinoma [15]
we observed that most tumours were diploid. This
seems not to be in keeping with the possibility of het-
erogeneity. The number of samples studied per tumour,
however, might have been too small to exclude this
possibility.
For the present study, our working hypothesis was
that although the majority of early gastric carcino-
mas (EGC) are genetically (in terms of DNA-ploidy)
homogeneous, some cases might show heterogene-
ity [22]. Heterogeneity, indicating the emergence of
variant DNA-stemlines, indicates tumour progression
and might therefore be preferentially found in larger
lesions that invade deeper than the mucosa. To test this
hypothesis, we extensively sampled 17 cases of EGC
in search for multiple DNA-stemlines. We compared
the DNA-ploidy results with clinicopathological vari-
ables, including patient survival, tumour size and depth
of invasion.
2. Material and methods
Seventeen cases of EGC diagnosed in gastrectomy
specimens obtained between 1976 and 1992 were used
for this study. These cases included eight intramucosal
carcinomas and nine tumours also invading the submu-
cosa. Only those cases were included for which mul-
Analytical Cellular Pathology 19 (1999) 67–72
ISSN 0921-8912 / $8.00 Ó 1999, IOS Press. All rights reserved
68 M.C. Osterheld et al. / Evaluation of heterogeneity of DNA ploidy in early gastric cancers
Fig. 1. (A) Shows a section from an EGC before microdissec-
tion. Note doted line limiting the area to be dissected (HE, ×2.4).
(B) Illustrates the dissected sample used for ploidy assessment (HE,
×2.4).
tiple histological samples were available. All available
gross and histological material was reviewed and clin-
ical data were obtained from pathology reports and
from referring clinicians.
In all gastrectomy specimens, the tumour was map-
ped in detail following the protocol of Mori [12], which
allowed detailed histological analysis of the tumours
and measurement of the size of the intramucosal and of
the submucosal components. The number of samples
for cytophotometric DNA analysis in each case was
calculated as a function of the maximal diameter of
the tumour (one sample per two centimetres/maximal
length). In addition one sample of normal gastric mu-
cosa was examined for each case. Hematoxylin and
eosin stained slides were screened to identify the intra-
mucosal and the submucosal components. In addition,
the tumors were classified according to their histologi-
cal type following the WHO classification [11].
For selective evaluation of DNA ploidy the intra-
mucosal and the infiltrative components were sepa-
rately sampled on the corresponding paraffin blocks,
by means of a dissecting microscope. Moreover, we
carried out a histological control of the blocks follow-
ing dissection (Fig. 1).
Seventy-six blocks were processed for DNA assess-
ment, with an average number of 4.5 blocks per case,
including samples from normal gastric mucosa.
All dissected blocks were processed following the
technique of Hedley [5]. Feulgen staining was done as
following: the slides were first hydrolysed in 5 N hy-
drochloric acid at 25◦C for 45 minutes. The hydrolysis
was stopped by rinsing in distilled water. They were
then stained with Schiff’s reagent (Schiff’s reagent
for microscopy, No 1.0933, Merck) for 60 minutes.
Sulfite rinse was used to remove surplus dye. They
were rinsed and dehydrated in subsequently changes
of alcohol 50%, 70%, ethanol alcohol and xylene for
3 minutes each before being coverslipped using Eu-
kitt mounting medium. DNA analysis was performed
on Feulgen-stained cytospins using an image analy-
sis system (SAMBA, Alcatel TITN Answare, Greno-
ble, France). A minimum of 150 nuclei was measured
per smear (300 nuclei for most cases). Only well pre-
served nuclei were selected by the operator using the
gallery program of SAMBA system (SAMBA, Alca-
tel TITN Answare, Grenoble, France). As a control
we used 30 to 50 human lymphocytes (external refer-
ence) with a coefficient of variation of 5% (average)
and 6.5% (maximal), and at least 6 tissue polymor-
phonuclear leukocytes (internal reference) when avail-
able. Histograms exhibiting a G0/1 main peak at 2C
were considered to be diploid (index 0.85–1.15). Con-
sidering that in normal tissues and most low-grade or
slowly proliferating neoplasms, approximately 85% of
the cell population form the G0/1 peak and 15% of the
cells in the S-phase and G2/M phases [2,19], we have
only considered as aneuploid the samples with more
than 15% of cells with a DNA-index in excess of 1.15.
A sample was considered tetraploid when a peak was
found between DNA indices of 1.70 and 2.30 compris-
ing at least 15% of the cells. Similarly, a triploid sam-
ple was defined by a DNA-index between 1.3 and 1.75.
All the events>1.15 and not displaying a tetraploid or
a triploid peak were considered hyperploid (cell pop-
ulation with an abnormal content of DNA considered
aneuploid but not corresponding to a defined peak).
The tumours analysed were divided into two groups,
diploid and aneuploid, the latter regardless of the sub-
type of aneuploidy (hyperploid, triploid or tetraploid).
A tumour was regarded heterogeneous when at least
one sample had a ploidy pattern different from the oth-
ers (Fig. 2). A tumour was considered diploid when all
samples were diploid (homogeneous). A tumour was
considered aneuploid when at least one sample was
aneuploid (heterogeneous) or all samples were ane-
uploid (homogeneous). Possible correlation between
ploidy and depth of tumour invasion or heterogeneity
were statistically analysed by means of the Fischer’s
exact test. A P value of less than 0.05 was considered
statistically significant.
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Fig. 2. Histograms illustrating intratumoral DNA-ploidy heterogeneity: *Normal mucosa diploid (a); **intramucosal component showing a
diploid (b) and an aneuploid (c) histogram; ***submucosal component ((d) and (e)) showing a variable degree of aneuploidy.
3. Results
We studied 17 patients (7 women, 10 men). Aver-
age age at gastrectomy was 60 years. All tumours were
located in the small curvature of the stomach, most
commonly in the antrum at the level of the angulus.
The macroscopic pattern was classified according to
the system proposed by the Japanese Society of Gas-
troenterological Endoscopy [14] into type I (protruded
type), type IIa (elevated type), b (flat type), c (de-
pressed type) or type III (excavated type) and corre-
sponded mainly to the types II and III. Follow-up data
were available of 15 patients. Twelve (87%) patients
were still alive 10 years after gastrectomy. One patient
presented liver metastases and died eight years after
surgery, another died five years after surgery with lo-
cal recurrence and lymph node metastases, and one pa-
tient died three years after surgery with multiple metas-
tases.
Of our tumours 8 (45%) were purely intramucosal
and 9 (55%) also contained areas of submucosal infil-
tration (Fig. 3). The size of the tumours varied between
7× 6 and 3.5× 2.5 cm. Tumours with submucosal in-
vasion were not significantly larger than those without.
The submucosal component comprised on the average
24% of the total size (range 3–71%). The DNA analy-
sis of all the normal gastric mucosa samples invariably
showed a diploid pattern (100%).
Of the 17 tumours, 9 (53%) were diploid and 8
(47%) aneuploid. Of the 8 intramucosal carcinomas,
5 (63%) were diploid and 3 (37%) aneuploid. Of the
9 submucosal tumours 5 (55%) were aneuploid and 4
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Fig. 3. View of a histological section cut through an area of intramucosal EGC (A) (HE, ×150) and through an area of infiltrating submucosa
EGC (B) (HE,×80).
Table 1
DNA-ploidy pattern in pure intramucosal EGC
Cases Age/sex Origin Size of EGC Samples DNA-ploidy Heterogeneity
i.m (cm× cm) Total* D A
1 70/M i.m 4.5× 2.5 3 3 0 D no
2 70/F i.m 5× 5 3 3 0 D no
3 81/F i.m 4.5× 2 3 0 3 A no
4 17/F i.m 5.5× 4 3 2 1 A yes
5 44/F i.m 6× 4 3 3 0 D no
6 42/F i.m 4× 3.5 2 2 0 D no
7 75/M i.m 5.5× 1 + 0.5× 0.5 3 0 3 A no
8 57/F i.m 5.5× 3.5 3 3 0 D no
Total 8 cases 23 samples 5 diploid
3 aneuploid 1 heterogeneous
D = DNA-diploid; A = DNA-aneuploid; i.m = intra-mucosal component; *Total = total number of samples analysed per
case.
(45%) diploid (P = 0.39). Heterogeneity was present
in 5 cases, one in intramucosal (1 of 8; 13%) but 4 (4 of
9; 44%) in submucosally infiltrating cases (P = 0.18).
Neither aneuploidy or heterogeneity were related to
the size of EGC (Tables 1 and 2). Furthermore, no
significant correlation was found between the differ-
ent histological types (WHO classification) and the in-
cidence of aneuploidy or heterogeneity. All available
lymph nodes were negative for metastases except for
case 9 with 2/8 metastatic lymph nodes.
4. Discussion
The malignant potential of different tumours has
been correlated with DNA-ploidy, and it has been
shown that the presence of aneuploid cell populations
frequently is an indicator of poor prognosis. Several
studies have been published on DNA-ploidy in gastric
cancer; most indicate that DNA-aneuploidy is an indi-
cator of unfavourable prognosis [1,7–9,20,21], but oth-
ers failed to confirm this finding [3].
Tumour heterogeneity has been a consistent finding
in DNA-ploidy analysis, e.g., of colorectal cancer [16,
27]. Sampling error of heterogeneous gastric tumours
could explain, at least partly, the conflicting results for
gastric cancer. DNA-ploidy studies in advanced gastric
cancers have confirmed that heterogeneity exists. It ap-
pears to occur more frequently in deeply invading tu-
mours, which suggests that advanced tumours might be
more heterogeneous [6,23]. If ploidy heterogeneity is a
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Table 2
DNA-ploidy patterns in EGC infiltrating mucosa and submucosa
Cases Age/sex Origin Size of EGC Samples DNA-ploidy Heterogeneity
i.m (cm × cm) s.m (cm × cm) Total* D A
1 66/M i.m 4× 2.5 2 2 0 A yes
s.m 0.5× 0.5 1 0 1
2 62/M i.m 5× 4 3 3 0 D no
s.m 1× 1 1 1 0
3 79/M i.m 5× 3.5 3 0 3 A no
s.m 5× 2.5 3 0 3
4 43/F i.m 4× 3.5 2 2 0 D no
s.m 2× 0.5 1 1 0
5 49/M i.m 7× 6 4 4 0 D no
s.m 0.5× 0.5 1 1 0
6 77/M i.m 7.5× 1.5 3 1 2 A yes
s.m 3× 0.5 2 1 1
7 66/M i.m 5.5× 2.5 3 1 2 A yes
s.m 2× 1.5 1 0 1
8 57/M i.m 0.5× 0.5 1 1 0 D no
s.m 3× 2.5 2 2 0
9 67/M i.m 6× 4 2 1 1 A yes
s.m 3× 2 2 0 2
Total 9 cases 37 samples 4 diploid
5 aneuploid 4 heterogeneous
D = DNA-diploid; A = DNA-aneuploid; i.m = intra-mucosal component; s.m = sub-mucosal component; *Total = total number of samples
analysed per case.
reflection of genetic instability, which might be an im-
portant mechanism in gastric cancer progression, a low
level of aneuploidy and of ploidy heterogeneity should
exist in early gastric cancer. To verify this hypothesis
we undertook the present study, of which the impor-
tance is that multiple tumour samples were studied.
Several findings emerge from this study. Firstly, of
our early gastric cancers 9 were entirely diploid and
8 had at least one aneuploid sample. Aneuploidy oc-
curred less frequently in purely intramucosal cancers
but this difference did not (because of the limited num-
ber of cases) attain statistical significance.
In a previous study of largely superficial gastric car-
cinomas but with focal infiltration of the muscularis
propria we found that both components are usually
diploid [15]. In this study, however, a limited number
of samples per tumour was analysed, which might be
the reason why no aneuploid case were detected. This
underscores the importance of extensive tumour sam-
pling for DNA-ploidy analysis.
Secondly, of the aneuploid cases, one was homoge-
neous and 5 heterogeneous. The heterogeneous cases
occurred mostly in the tumours with invasion into the
submucosa (4 of 9; 44%) but rarely in purely intramu-
cosal (1 of 8; 13%). Most aneuploid tumours invad-
ing the submucosa were heterogeneous, which again
underscores the importance of adequate sampling (one
sample per two centimetres/maximal length) of the le-
sions for reliable cytometric assessment.
Our data are consistent with existing progression
models of human cancer. In a purely diploid early can-
cer genetic instability leads to a more aggressive (pur-
portedly more invasive) cell clone, which is reflected in
DNA-ploidy heterogeneity. Overgrowth by this clone
of the tumour eventually leads to homogeneous aneu-
ploidy [4,6,17,22].
In conclusion, our study, (1) confirms the presence
of aneuploid early gastric carcinomas; (2) reveals that
these aneuploid tumours are frequently heterogeneous;
and (3) suggests that heterogeneity occurs more fre-
quently in tumours invading the submucosa. Adequate
sampling of tumours is essential for reliable ploidy as-
sessment.
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